The Manufacturers Life Insurance Company Sells 169 Shares of Chemed Co. (NYSE:CHE)

The Manufacturers Life Insurance Company trimmed its stake in Chemed Co. (NYSE:CHE) by 1.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,110 shares of the company’s stock after selling 169 shares during the period. The Manufacturers Life Insurance Company owned 0.09% of Chemed worth $7,113,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. Rise Advisors LLC bought a new position in shares of Chemed in the first quarter valued at approximately $26,000. GAMMA Investing LLC lifted its position in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the last quarter. Mather Group LLC. bought a new stake in Chemed during the first quarter valued at about $67,000. EntryPoint Capital LLC boosted its holdings in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares during the period. Finally, Janiczek Wealth Management LLC grew its position in shares of Chemed by 154.5% in the first quarter. Janiczek Wealth Management LLC now owns 196 shares of the company’s stock valued at $126,000 after purchasing an additional 119 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

NYSE CHE opened at $581.55 on Friday. The stock has a 50-day simple moving average of $579.20 and a 200 day simple moving average of $573.94. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The stock has a market capitalization of $8.80 billion, a PE ratio of 31.30, a P/E/G ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period in the prior year, the company posted $4.71 earnings per share. The firm’s revenue was up 7.6% compared to the same quarter last year. As a group, equities research analysts forecast that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio is currently 10.76%.

Insider Activity at Chemed

In related news, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 9,144 shares of company stock worth $5,264,839. Company insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.